CannabisNewsBreaks Archive - Page 151 of 429

FridayJun 05, 2020 9:48 am

CannabisNewsBreaks – SinglePoint, Inc. (SING) President Discusses Online Solar Purchasing Platform and 1606 Hemp Expansion on MoneyTV with Donald Baillargeon

SinglePoint (OTCQB: SING) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program covers money-focused topics, featuring various companies and in-depth interviews with CEOs and executives that offer insights into operations and future outlooks. MoneyTV is viewed in over 200 million households in more than 75 countries. Among other highlights from this week’s program, SinglePoint President Wil Ralston discussed the company’s implementation of an online purchasing platform to streamline the process for solar customers. The interview also covers expansion of the company's 1606 Hemp brand, which is now sold in over 400 stores. “We’re continuing…

FridayJun 05, 2020 9:21 am

CannabisNewsBreaks – ChineseInvestors.com Inc. (CIIX) CEO Provides Business Update on MoneyTV with Donald Baillargeon

ChineseInvestors.com (OTCQB: CIIX) was featured on this week’s episode of MoneyTV with Donald Baillargeon. The internationally syndicated program, viewed in over 200 million households and more than 75 countries, covers money-focused topics and features in-depth interviews with CEOs and executives offering insights into various companies and their operations and future outlooks. Among other highlights, this week’s episode featured CEO Warren Wang as he announced that the company recently received government stimulus funding. “I'm so glad that we still have 60 employees, we still have a big payroll,” CIIX CEO Warren Wang stated in the interview. “We received the government money…

ThursdayJun 04, 2020 2:14 pm

CannabisNewsBreaks – Champignon Brands Inc. (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496) Names New CEO

Champignon Brands (CSE: SHRM) (OTCQB: SHRMF) (FWB: 496), a human-optimization sciences company with an emphasis on ketamine and psychedelic medicine, recently named Dr. Roger McIntyre as chief executive officer. An article discussing the company reads, “In his new role, Dr. Roger McIntyre brings impressive experience in the ketamine and psychedelic medicine space, a key focus area for Champignon. . . . ‘My overarching aim as chief executive officer is to establish Champignon as the apotheosis of integrated ketamine treatment delivery and the commercialization of our own IP psychedelic-based treatments,’ McIntyre stated in a news release. ‘The clinical infrastructure, complementary asset…

ThursdayJun 04, 2020 11:21 am

CannabisNewsBreaks – Cannabis Strategic Ventures, Inc. (NUGS) on Pace to $11 Million in Annualized Sales

Cannabis Strategic Ventures (OTCQB: NUGS), an emerging leader in the U.S. cannabis marketplace, today announced new projections for calendar Q2 sales. According to the update and based on its performance in April and May, the Company is now on pace for over $2.7 million in quarterly sales and approximately $11 million in annualized sales. “We believe we can drive further significant organic growth from current levels,” Simon Yu, CEO of Cannabis Strategic Ventures, stated in the news release. “Current performance is being driven by multiple factors, including volume, capacity and pricing, all aligning with a strong macro environment in the…

ThursdayJun 04, 2020 10:49 am

CannabisNewsBreaks – Sugarmade, Inc.’s (SGMD) BudCars Achieves Record May Sales, Continues to See 10% Week-Over-Week Growth

Sugarmade (OTCQB: SGMD), together with its BudCars Cannabis Delivery Service (“BudCars”), today announced record growth data for BudCars sales during the month of May. According to the update, the company posted nearly 30% sequential monthly growth over April sales and continues to see week-over-week sales growth at 10%, which suggests that BudCars will surpass $10 million in annualized sales by the month of August at its Sacramento location. “The top-line growth data has been extremely strong, and we have no reason to expect that to change. But it’s important that our shareholders understand that this is not a delivery service…

ThursdayJun 04, 2020 9:47 am

CannabisNewsBreaks – Canopy Rivers Inc. (TSX: RIV) (OTC: CNPOF) Announces Financial Highlights, Corporate Milestones for Q4 and FY 2020

Canopy Rivers (TSX: RIV) (OTC: CNPOF), a venture capital firm specializing in cannabis, on Wednesday released its audited consolidated financial statements for the fiscal year ended March 31, 2020 ("FY 2020") and management's discussion and analysis ("MD&A") for the three and twelve months ended March 31, 2020. "The global economic uncertainty brought on by COVID-19 capped off a volatile and challenging year for the cannabis sector. Despite these challenges, I am pleased with what our team achieved last year. However, we were not immune to this volatility, and following a strategic and operational review of our business, we recently announced…

WednesdayJun 03, 2020 11:32 am

CannabisNewsBreaks – Cannabis Global, Inc. (MCTC) Discusses Strong Solution with Expected 50%+ Cost Advantage in Production of THC-V and Other Rare Cannabinoids

Cannabis Global (OTC: MCTC), a cannabinoid and hemp extract science-forward company developing infusion and delivery technologies, today announced information on its Project Varin, a nearly complete research program implemented to develop novel production technologies for rare cannabinoids, including tetrahydrocannabivarin (“THC-V”), which is not scheduled at the federal level. According to the update, the program has produced meaningful technology breakthroughs resulting in several patent filings. The company has been able to leverage these technological developments to significantly reduce the cost of exotic cannabinoids on a per-serving basis resulting in a greater than 50% expected cost advantage. “We think we have rewritten…

WednesdayJun 03, 2020 9:41 am

CannabisNewsBreaks – Green Growth Brands Inc. (CSE: GGB) (OTCQB: GGBXF) Announces Update on Insolvency Proceedings Under the CCAA

Green Growth Brands (CSE: GGB) (OTCQB: GGBXF) and certain of its direct and indirect wholly owned subsidiaries (collectively "GGB", the "company" or the “Applicants”) on Tuesday released an update on its insolvency proceedings under the Companies’ Creditors Arrangement Act (Canada) ("CCAA"). As announced on May 20, 2020, GGB filed for insolvency protection under the CCAA and obtained an order from the Ontario Superior Court of Justice (the “Court”) granting protection for an initial 10 day period until May 29, 2020, as extended until June 12, 2020. According to the update, the Court, on June 2, 2020, granted a motion filed…

TuesdayJun 02, 2020 11:09 am

CannabisNewsBreaks – Wildflower Brands Inc. (CSE: SUN) (OTC: WLDFF) Announces $5.3 Million in Revenues for Q3

Wildflower Brands (CSE: SUN) (OTC: WLDFF) today announced $5.3 million in revenues in its third quarter, compared to $2.5 million in the previous year’s third quarter and $5.5 million in the second quarter. According to the update, revenues were slightly less than last quarter; however, even with unforeseen circumstances and business affected by Covid-19, Wildflower was able to operate with a net gain of $101,435 compared to a loss of $(1,019,862) in the third quarter of 2019. Wildflower’s U.S. operations have been curtailed due to the closure of many retail locations where the Company’s products are sold. Manufacturing and sales…

TuesdayJun 02, 2020 10:40 am

CannabisNewsBreaks – Cardiol Therapeutics Inc. (TSX: CRDL) (OTCQX: CRTPF) to Secure $11.25 Million in Bought Deal Public Offering

Cardiol Therapeutics (TSX: CRDL) (OTCQX: CRTPF), a leader in the production of pharmaceutical cannabidiol (“CBD”) and the development of innovative cannabidiol products for heart diseases, recently announced its entry into an agreement with Canaccord Genuity Corp. (the "Lead Underwriter"). Under the arrangement, the Lead Underwriter agreed, on behalf of a syndicate of underwriters, to purchase, on a bought deal basis per the filing of a short form prospectus, an aggregate of 4,500,000 units, each at a price of $2.50, for aggregate gross proceeds of $11,250,000 to the Company. Cardiol intends to use the proceeds to support commercialization of its pharmaceutical…

News and publishing service for cannabis related companies

Contact us: 512.354.7000

CannabisNewsBreaks